COVID-19 and lung side effects from breast cancer radiation
Part of Cancer, Infections, Injuries & trauma, Lungs & breathing, Skin clinical trials.
This study looks at whether getting COVID-19 before or during radiation treatment for breast cancer increases the chance of lung inflammation (radiation pneumonitis). It may help understand risks and improve care for patients who had COVID-19.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have breast cancer that was confirmed by a biopsy or other lab test.
- You are between 18 and 79 years old.
- If you had COVID-19, you have a positive test result on record.
- You have not had radiation therapy to the chest area before.
- You do not have any other lung cancer or active lung infections other than COVID-19.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how radiation therapy for breast cancer may affect your lungs over time. Researchers will measure lung function and see if problems develop, so they can better understand and protect patients.
This study looks at why some people develop long-term lung problems after COVID-19. It compares people who had severe COVID-19 and were hospitalized to those who had mild infections and recovered at home.
This study asks adult cancer patients to complete a survey and talk in an interview about how COVID-19 affected their care and daily life. Your answers may help researchers understand what challenges cancer patients faced during the pandemic.
This trial is testing how well the COVID-19 vaccine works for people with lung cancer to prevent another infection. It also looks at certain biomarkers in your blood that might help predict your body's immune response.
This study looks at cells from the lungs of people who developed lung inflammation after chest radiation for cancer. It aims to understand why some people get this reaction, which may help find better treatments.
This study looks at using blood and imaging markers to predict if patients with lung cancer who receive both immunotherapy and chest radiation will develop lung inflammation (called radiation lung injury). It may help doctors personalise care and reduce side effects.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.